Monday, January 8, 2024

Current Funding Opportunities Update

NIH NIDDK

Current Funding Opportunities

01/04/2024 

This NOFO invites applications for investigator-initiated, high-risk multi-center clinical trials involving more than one clinical center. Proposed trials should be hypothesis-driven, have the potential to change clinical practice and/or public health, and focus on a disease relevant to the mission of NIDDK. Planning activities must be completed prior to submission and are not permitted under this NOFO. Applicants who require a planning phase may first apply for an implementation planning cooperative agreement (U34; see PAR-24-094). Consultation with NIDDK Scientific/Research staff is strongly encouraged prior to the submission of either a U34 or U01 application.
This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Tracy Rankin, Ph.D., M.P.H.; Barbara Linder, M.D., Ph.D.; Aynur Unalp-Arida, M.D., Ph.D. | PAR-24-103
01/04/2024 

This NOFO invites applications for investigator-initiated, high-risk multi-center observational studies involving more than one clinical center. Proposed studies should be hypothesis-driven and focus on a disease relevant to the mission of NIDDK. Planning activities must be completed prior to submission and are not permitted under this NOFO. Applicants who require a planning phase may first apply for an implementation planning cooperative agreement (U34; see PAR-24-094). Consultation with NIDDK Scientific/Research Staff strongly encouraged prior to the submission of either a U34 or U01 application.
This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Tracy Rankin, Ph.D., M.P.H.;Barbara Linder, M.D., Ph.D.;Aynur Unalp-Arida, M.D., Ph.D. | PAR-24-102
01/04/2024

NIDDK supports investigator-initiated, high-risk multi-center (more than one center) clinical studies through a two-part process that may include an implementation planning cooperative agreement (U34). The U34 is designed to: 1) Permit early peer review of the rationale for the proposed clinical study; 2) Permit assessment of the design and protocol of the proposed study; 3) Provide support for the development of documents needed for the conduct of the study, including a manual of operations; and 4) Support the development of other essential elements required for the conduct of the clinical study. The proposed clinical study should be hypothesis-driven and focus on a disease in the mission of NIDDK. Consultation with NIDDK scientific staff is strongly encouraged prior to the submission of the U34 application.
Tracy Rankin, Ph.D., M.P.H.;Barbara Linder, M.D., Ph.D.;Aynur Unalp-Arida, M.D., Ph.D. | PAR-24-094
01/02/2024 12:00 AM EST

The NIH Office of Science Policy (OSP) within the Office of the Director (OD) announces the availability of administrative supplements to support 1) research on bioethical issues to develop or support the development of an evidence base that may inform future policy directions, and/or 2) certain efforts to develop or augment bioethics research capacity. Applicants may propose to supplement parent awards focused on bioethics or biomedical and/or health-related behavioral research. The proposed bioethics question, issue, or topic must be clearly articulated. All applications must be within the scope of the parent award. Aynur Unalp-Arida, MD, MSc, PhD | NOT-OD-24-031

View All Funding Opportunities


This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 1 Information Way, Bethesda, MD 20892 · 1-800-860-8747

No comments:

Post a Comment

Your Weekly Recommended Reads

Powered by AI, personalised for you Catch up on key news and analysis from the week gone by with The Business of Fashion's My...